指南与共识腹部技术与安全US

超声肝脏影像报告和数据系统:用于肝细胞癌筛查与监测的US LI-RADS

US LI-RADS: ultrasound liver imaging reporting and data system for screening and surveillance of hepatocellular carcinoma.
PubMed 文献 · Abdom Radiol (NY) · 2018-01-01

美国放射学会制定了超声肝脏影像报告和数据系统(US LI-RADS)算法,用于肝细胞癌筛查与监测。该算法包含检测评分(US-1阴性、US-2亚阈值、US-3阳性)和可视化评分(A无或轻微限制、B中度限制、C严重限制),旨在标准化高危人群的超声应用、报告和管理。

要点

  • US-1阴性、US-2亚阈值、US-3阳性三类检测评分用于指导管理。
  • 可视化评分A/B/C分别代表无或轻微、中度、严重限制,反映检查预期敏感度。
  • 标准化高危人群超声筛查与监测有望改善沟通并统一算法。

核心结论

  • US LI-RADS为肝细胞癌筛查与监测的超声解读、报告和管理提供标准化框架,有望改善患者和转诊医师沟通、统一筛查监测算法、影响结局并为未来研究提供定量数据。

研究设计与样本

  • 美国放射学会(ACR)制定的US LI-RADS算法,包含检测评分和可视化评分两个组成部分。

诊断标准与关键数值

  • 检测评分:US-1阴性、US-2亚阈值、US-3阳性;可视化评分:A无或轻微限制、B中度限制、C严重限制。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Ultrasound is the most widely used imaging tool for hepatocellular carcinoma (HCC) screening and surveillance. Until now, this method has lacked standardized guidelines for interpretation, reporting, and management recommendations [1-5]. To address this need, the American College of Radiology (ACR) has developed the Ultrasound Liver Imaging Reporting and Data System (US LI-RADS) algorithm. The proposed algorithm has two components: detection scores and visualization scores. The detection score guides management and has three categories: US-1 Negative, US-2 Subthreshold, and US-3 Positive. The visualization score informs the expected sensitivity of the ultrasound examination and also has three categories: Visualization A: No or minimal limitations; Visualization B: Moderate limitations; and Visualization C: Severe limitations. Standardization in ultrasound utilization, reporting, and management in high-risk individuals has the capacity to improve communication with patients and referring physicians, unify screening and surveillance algorithms, impact outcomes, and supply quantitative data for future research.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Morgan TA, Maturen KE, Dahiya N, et al. US LI-RADS: ultrasound liver imaging reporting and data system for screening and surveillance of hepatocellular carcinoma. Abdom Radiol (NY). 2018. PMID: 28936543. doi:10.1007/s00261-017-1317-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。